REVVITY, INC. RVTY

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $116.77
Market Cap $13.11B
P/E Ratio 56.41
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑3.7% YoY
$2.86B
3-Yr CAGR: 56.8%
Net Income ↓-10.8% YoY
$241.20M
Net Margin: 8.4%
Free Cash Flow ↓-6.0% YoY
$509.41M
FCF Yield: 3.89%
EPS (Diluted) ↓-5.9% YoY
$2.07
Basic: $2.07
Return on Equity Efficiency
3.3%
ROA: 2.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (RVTY)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $2,262.4M $286.1M $212.4M $287.1M $257.5M
FY 2017 $2,257.0M -0.2% $1,073.0M $292.6M +37.8% $2.64 $288.5M $249.4M -3.1%
FY 2018 $2,778.0M +23.1% $1,340.9M $237.9M -18.7% $2.13 -19.3% $311.0M $217.8M -12.7%
FY 2019 $2,883.7M +3.8% $1,396.1M $227.6M -4.4% $2.04 -4.2% $363.5M $287.1M +31.8%
FY 2020 $3,782.7M +31.2% $2,109.9M $727.9M +219.9% $6.49 +218.1% $892.2M $814.7M +183.7%
FY 2021 $5,067.2M +34.0% $2,559.9M $943.2M +29.6% $8.08 +24.5% $1,410.8M $1,310.9M +60.9%
FY 2022 $741.2M -85.4% $433.1M $943.2M 0.0% $1,410.8M $1,310.9M 0.0%
FY 2023 $2,750.6M +271.1% $1,323.1M $693.1M -26.5% $5.55 $91.3M $9.9M -99.2%
FY 2024 $2,755.0M +0.2% $1,340.8M $270.4M -61.0% $2.20 -60.4% $628.3M $541.7M +5,369.0%
FY 2025 $2,856.1M +3.7% $1,348.5M $241.2M -10.8% $2.07 -5.9% $582.9M $509.4M -6.0%
$

Valuation

Market Price $116.77
Market Cap $13.11B
Enterprise Value $15.41B
P/E Ratio 56.41
P/B Ratio 1.80
FCF Yield 3.89%
Dividend Yield 0.24%
Shares Outstanding 111,559,800
%

Profitability & Margins

Gross Margin 47.22%
Operating Margin 12.49%
Net Margin 8.45%
Return on Equity (ROE) 3.33%
Return on Assets (ROA) 1.98%
Asset Turnover 0.23x
Revenue 3-Yr CAGR 56.77%
🛡️

Financial Health & Liquidity

Current Ratio 4.02
Cash Ratio 1.65
Debt / Equity 0.444
Debt / Assets 0.265
Cash & Equivalents $919.86M
Total Debt $3.22B
Book Value / Share $64.99
💧

Cash Flow Efficiency

Operating Cash Flow $582.93M
Capital Expenditures (CapEx) $73.52M
Free Cash Flow $509.41M
OCF / Revenue 20.41%
FCF / Revenue 17.84%
FCF 3-Yr CAGR -27.03%
🏷️

Per Share Metrics

EPS (Diluted) $2.07
EPS (Basic) $2.07
Dividends / Share $0.28
Book Value / Share $64.99
EPS YoY Growth -5.91%
🏛️

Balance Sheet (FY 2025)

Total Assets $12.17B
Total Liabilities $12.17B
Stockholders' Equity $7.25B
Current Assets $2.24B
Current Liabilities $556.95M